Cargando…

Late-onset Pompe disease manifests in the brain

Detalles Bibliográficos
Autor principal:	Finsterer, Josef
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6595077/ https://www.ncbi.nlm.nih.gov/pubmed/31293897 http://dx.doi.org/10.1016/j.ymgmr.2019.100488

Ejemplares similares

Response: Late-onset Pompe disease manifests in the brain
por: Schneider, Ilka, et al.
Publicado: (2019)

Enzyme replacement therapy and antibodies in late-onset Pompe disease
por: Schneider, I., et al.
Publicado: (2014)

Dilative arteriopathy in Pompe disease may not only affect the cerebral arteries
por: Finsterer, Josef
Publicado: (2018)

Late‐onset Pompe disease with a novel mutation and a rare phenotype: A case report
por: Si, Xiaoli, et al.
Publicado: (2022)

Functional capacity in a late-onset Pompe disease patient: Effect of enzyme replacement therapy and exercise training
por: Krase, Argyro A., et al.
Publicado: (2016)

Is the brain involved in patients with late‐onset Pompe disease?
por: van den Dorpel, Jan J. A., et al.
Publicado: (2022)

Is early detection of late-onset Pompe disease a pneumologist’s affair? A lesson from an Italian screening study
por: Confalonieri, Marco, et al.
Publicado: (2019)

Hypothyroidism in late-onset Pompe disease
por: Schneider, Joseph, et al.
Publicado: (2016)

Infantile onset Pompe disease presenting with non-immune hydrops fetalis
por: Lee, Kristen, et al.
Publicado: (2019)

Adenotonsillectomy should be avoided whenever possible in infantile-onset Pompe disease
por: Jones, Harrison N., et al.
Publicado: (2020)

Respiratory manifestations in late-onset Pompe disease: a case series conducted in Brazil
por: Sixel, Bruna de Souza, et al.
Publicado: (2017)

Rare Phenotypic Manifestations of MELAS
por: Finsterer, Josef
Publicado: (2020)

ATAD3A variants manifest multisystematically in the brain, nerves, eyes, heart, liver, and skin
por: Finsterer, Josef, et al.
Publicado: (2020)

Late-Onset Pompe Disease with Nemaline Bodies
por: Frezza, E., et al.
Publicado: (2018)

Pregnancy Outcomes in Late Onset Pompe Disease
por: Goker-Alpan, Ozlem, et al.
Publicado: (2020)

NDUFAF5 variants manifest phenotypically heterogeneously
por: Finsterer, Josef
Publicado: (2018)

Fatigue: an important feature of late-onset Pompe disease
por: Hagemans, M. L. C., et al.
Publicado: (2007)

Bone density in patients with late onset Pompe disease
por: Papadimas, George, et al.
Publicado: (2012)

Treatment Dilemma in Children with Late-Onset Pompe Disease
por: Faraguna, Martha Caterina, et al.
Publicado: (2023)

A Comprehensive Update on Late-Onset Pompe Disease
por: Labella, Beatrice, et al.
Publicado: (2023)

Primary Pulmonary Hypertension as a Manifestation of Adult Multi-System Mitochondrial Disorder
por: Finsterer, Josef
Publicado: (2009)

Pituitary apoplexy is not uncommon in pediatric patients and can be a manifestation of neuro-COVID
por: Finsterer, Josef
Publicado: (2023)

Complex-I defect with minimal manifestations
por: Finsterer, Josef, et al.
Publicado: (2014)

Management of manifesting FOXRED1 carriers is complex
por: Finsterer, Josef, et al.
Publicado: (2019)

Pain in adult patients with Pompe disease
por: Karabul, N., et al.
Publicado: (2014)

Recommendations for Infantile-Onset and Late-Onset Pompe Disease: An Iranian Consensus
por: Fatehi, Farzad, et al.
Publicado: (2021)

Aseptic meningitis as a manifestation of a mitochondrial disorder
por: Finsterer, Josef, et al.
Publicado: (2016)

Leigh syndrome can manifest with intracranial calcifications and bleedings
por: Finsterer, Josef, et al.
Publicado: (2022)

Comment on: Neurological Manifestations Associated With SARS-CoV-2 in Children: A Case Series
por: Finsterer, Josef
Publicado: (2022)

Reply to: ‘Advances in imaging of brain abnormalities in neuromuscular disease’
por: Finsterer, Josef
Publicado: (2019)

Bright tongue sign in patients with late-onset Pompe disease
por: Karam, Chafic, et al.
Publicado: (2019)

Dynamic respiratory muscle function in late-onset Pompe disease
por: Smith, Barbara K., et al.
Publicado: (2019)

S1.5 Role of the pulmonologist in the late-onset Pompe disease
por: Fiorentino, Giuseppe, et al.
Publicado: (2011)

Walking delay as leading symptom in late-onset Pompe disease
por: Gökce, S, et al.
Publicado: (2013)

Highlighting intrafamilial clinical heterogeneity in late-onset Pompe disease()
por: Papadopoulos, C., et al.
Publicado: (2013)

Analysis of voice quality in patients with late-onset Pompe disease
por: Szklanny, Krzysztof, et al.
Publicado: (2016)

COVID‐19 infection in patients with late‐onset Pompe disease
por: Avelar, Jennifer, et al.
Publicado: (2022)

Late-Onset Pompe Disease Presenting with Isolated Tongue Involvement
por: Al-Hashel, Jasem, et al.
Publicado: (2022)

Vaccination triggering onset of m.8993T > G associated Leigh syndrome
por: Finsterer, Josef, et al.
Publicado: (2018)

Alglucosidase alfa: 5 years of experience in late-onset Pompe disease
por: Schoser, Benedikt
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_qocuapn8vrmuvo87fcsu52u2pg